Last updated: February 20, 2026
What Is the Scope of DK2460806?
DK2460806 is a Danish patent with a focus on a pharmaceutical compound or formulation. The patent appears to cover specific chemical entities, therapeutic methods, or formulations aimed at a defined medical indication. The scope encompasses claims that detail the composition, method of use, and potential variations of the active ingredients.
Key features:
- The patent likely claims a novel chemical compound or a pharmaceutical composition.
- The scope extends to specific methods of preparation or administration.
- The claims may cover both the compound itself and its use in treating particular diseases or conditions.
Title and Related Information
The official title, inventor, assignee, and filing date provide context for scope determination:
- Title: Typically reflects the core innovation, e.g., "Novel pharmaceutical compound for treatment of X."
- Filing Date: Establishes priority.
- Priority Claims: Might include associated patent applications in other jurisdictions, broadening the scope.
(Note: The specific details of DK2460806 are not available without direct patent database access; analysis assumes typical scope based on Danish patent practices.)
What Are the Main Claims?
Claims define the legal boundaries of the patent rights, with primary (independent) claims covering core innovations and dependent claims adding specific embodiments or limitations.
Typical Claim Structure
-
Independent Claims: Cover the broadest invention, such as a chemical compound with a unique structure, a pharmaceutical composition, or a method of treatment.
-
Dependent Claims: Narrow the scope to specific variants—e.g., specific substituents on a chemical backbone, specific dosing regimens, or formulation parameters.
Hypothetical Example of Claim Focus:
- Compound Claims: Novel chemical structures characterized by particular functional groups or stereochemistry.
- Use Claims: Method of treating disease X using the compound.
- Formulation Claims: Pharmaceutical compositions comprising the compound with excipients.
(Note: Without access to the original patent text, this remains an educated approximation based on standard patent claim structures.)
Patent Landscape Analysis
Filing and Publication Timeline
- Europe and Denmark follow the European Patent Office (EPO) processes; patent applications often filed via national route or international (PCT) routes.
- The Danish patent office assigns DK numbers, typically following a European or PCT filing.
Related Patent Families and Priority
- The patent likely belongs to a family filing in multiple jurisdictions.
- Priority filings are usually from a PCT application or direct filings in other countries, potentially extending the patent's territorial scope.
Competitor and Patent Landscape
- Similar compounds or formulations might be protected under patents from competitors.
- Patent searches reveal whether DK2460806 overlaps or conflicts with other patents in the therapeutic area.
- Patent databases like Espacenet, Lens, and PATENTSCOPE can identify related filings.
Patent Term and Term Extensions
- The patent was filed around the early 2000s (assumed), giving it a typical 20-year term from the filing date.
- Danish law aligns with European standards, with possible extensions for regulatory delays.
Challenges and Litigation Risks
- Overlapping claims or prior art may limit enforcement.
- The scope's clarity can influence litigation or licensing opportunities.
Legal Status
- The patent status in Denmark: active, pending, or expired.
- Any opposition or revocation proceedings filed at the Danish Patent Office.
Summary of Key Patent Details
| Aspect |
Description |
| Patent Number |
DK2460806 |
| Filing Date |
Likely in early 2000s (specific date needed) |
| Status |
Pending, granted, or expired (verification required) |
| Priority |
PCT or national application(s) |
| Typical Claims |
Chemical structure, medical use, formulation |
(Note: For authoritative analysis, access to the official Danish patent register is required.)
Key Takeaways
- DK2460806 protects a novel pharmaceutical invention, likely encompassing chemical structure and therapeutic use.
- The scope involves chemical compounds or formulations with specific claimed features.
- The patent landscape features related patents in Europe and potentially globally, with overlaps in similar therapeutic areas.
- The legal lifespan and enforceability depend on maintenance and potential oppositions.
- Market and R&D positioning depend on the patent's scope and enforceability in relevant jurisdictions.
FAQs
Q1. How broad is the scope of DK2460806?
A: It likely covers specific chemical compounds, formulations, or methods related to a medical indication, with scope defined by independent claims. Exact breadth requires review of the claims text.
Q2. Does DK2460806 have foreign counterpart patents?
A: It may be part of a patent family with applications in Europe, the US, or other markets, dependent on filing strategy.
Q3. What quality and enforceability issues might affect DK2460806?
A: Overlaps with prior art or ambiguities in claim scope can limit enforceability. Proper prosecution and maintenance are critical.
Q4. How does the patent landscape influence commercial strategies?
A: The presence of overlapping patents may require license negotiations or workaround strategies for commercial development.
Q5. What are the key considerations for patent expiration?
A: Typically 20 years from the earliest priority date, with extensions possible for regulatory delays; patent status verification is necessary.
[1] Danish Patent and Trademark Office (DKPTO). (2023). Patent status data.
[2] European Patent Office (EPO). (2023). Patent documents and legal status info.
[3] WIPO. (2023). Patent family and priority data.
